Literature DB >> 24071659

The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation.

Karl J Neff1, Andrew H Frankel, Frederick W K Tam, Denise M Sadlier, Catherine Godson, Carel W le Roux.   

Abstract

Renal dysfunction and disease, including hyperfiltration, proteinuria and hypofiltration, are commonly associated with obesity. Diabetic kidney disease is also common in obese cohorts. Weight loss interventions, including bariatric surgery, can effectively reduce weight and improve renal outcomes. Some of this effect may be due to the remission of Type 2 diabetes and hypertension. However, other mechanisms, including the resolution of inflammatory processes, may also contribute. The effect of bariatric surgery on renal function has only recently become a focus of particular investigation. In this study, we will review the effects of bariatric surgery on obesity-associated kidney disease. We will discuss the pitfalls in assessing renal function in obese cohorts and will examine the effect of bariatric surgery on renal function and urinary protein excretion using different mechanisms. We will give particular attention to the evidence for bariatric surgery in cohorts with established renal disease and suggest future directions. In particular, we will outline the evidence for inflammation as an important therapeutic target, and the emerging medical therapies being considered to exploit this target in obesity- and diabetes-related kidney disease.

Entities:  

Keywords:  albuminuria; bariatric surgery; inflammation; kidney disease; proteinuria; renal function

Mesh:

Year:  2013        PMID: 24071659     DOI: 10.1093/ndt/gft262

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  17 in total

Review 1.  Anaesthetic Preparation of Obese Patients: Current Status on Optimal Work-up.

Authors:  Asta Lukosiute; Anil Karmali; Jonathan Mark Cousins
Journal:  Curr Obes Rep       Date:  2017-09

2.  Bariatric surgery is associated with renal function improvement.

Authors:  Carla N Holcomb; Lauren E Goss; Ammar Almehmi; Jayleen M Grams; Britney L Corey
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

3.  Estimated GFR Before and After Bariatric Surgery in CKD.

Authors:  Talha H Imam; Heidi Fischer; Bocheng Jing; Raoul Burchette; Shayna Henry; Stephen F DeRose; Karen J Coleman
Journal:  Am J Kidney Dis       Date:  2016-12-04       Impact factor: 8.860

4.  Determinants of Evolution of Glomerular Filtration Rate After Bariatric Surgery: a 1-Year Observational Study.

Authors:  Muriel Coupaye; Martin Flamant; Ouidad Sami; Daniela Calabrese; Simon Msika; Catherine Bogard; Emmanuelle Vidal-Petiot; Séverine Ledoux
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

5.  Predicting the glomerular filtration rate in bariatric surgery patients.

Authors:  Allon N Friedman; Sharon Moe; William F Fadel; Margaret Inman; Samer G Mattar; Zak Shihabi; Sara K Quinney
Journal:  Am J Nephrol       Date:  2013-12-19       Impact factor: 3.754

6.  Can childhood obesity influence later chronic kidney disease?

Authors:  Lyda Jadresic; Richard J Silverwood; Sanjay Kinra; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

Review 7.  Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.

Authors:  Tianhua Xu; Zitong Sheng; Li Yao
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

Review 8.  Therapeutic approaches to diabetic nephropathy--beyond the RAS.

Authors:  Beatriz Fernandez-Fernandez; Alberto Ortiz; Carmen Gomez-Guerrero; Jesus Egido
Journal:  Nat Rev Nephrol       Date:  2014-05-06       Impact factor: 28.314

Review 9.  Transplant options for patients with type 2 diabetes and chronic kidney disease.

Authors:  Costas Fourtounas
Journal:  World J Transplant       Date:  2014-06-24

Review 10.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.